Futura Medical hails results as erectile dysfunction drug drives sales
(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed.
Read moreWed, 16th Sep 2020 12:44
(Alliance News) - Futura Medical PLC on Wednesday celebrated its "first set out meaningful revenues" in 2023, as sales for its erectile dysfunction treatment climbed.
Read moreThursday 4 April | |
LungLife AI Inc | Full Year Results |
Friday 5 April | |
no events scheduled | |
Monday 8 April | |
Bango PLC | Full Year Results |
Ferrexpo PLC | Trading Statement |
Globaltrans Investment PLC | Full Year Results |
Tuesday 9 April | |
Alliance Pharma PLC | Full Year Results |
CMC Markets PLC | Trading Statement |
hVIVO PLC | Full Year Results |
Imperial Brands PLC | Trading Statement |
JTC PLC | Full Year Results |
S&U PLC | Full Year Results |
Ultimate Products PLC | Half Year Results |
Wednesday 10 April | |
Churchill China PLC | Full Year Results |
Futura Medical PLC | Full Year Results |
M&C Saatchi PLC | Full Year Results |
Marshalls PLC | Full Year Results |
Tesco PLC | Full Year Results |
Comments and questions to newsroom@alliancenews.com | |
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional. | |
Copyright 2024 Alliance News Ltd. All Rights Reserved. |
Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year.
Read more(Alliance News) - Stock prices in London pushed higher on Tuesday, with the FTSE 100 registering its first rise in four trading days, with oil major BP the star performer.
Read more(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.
Read more(Sharecast News) - Consumer healthcare company Futura said on Tuesday that 2023 had been a "transformational year", with the group generating its first meaningful revenues and laying the foundations for "significant growth acceleration".
Read more(Sharecast News) - Sexual health product developer Futura Medical announced an extension of its exclusive licensing agreement with Cooper Consumer Health on Monday.
Read more(Alliance News) - Futura Medical PLC on Monday said that it has extended its exclusive licensing agreement with Cooper Consumer Health Group, a European self-care organisation, to January 2029.
Read more(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Read more(Alliance News) - Futura Medical PLC on Wednesday said the Mexican Secretariat of Health has granted over the counter sale marketing authorisation for its erectile dysfunction topical gel formulation Eroxon.
Read moreFutura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says that it has launched Exoron in the United Arab Emirates. Exoron, or MED3000, is a topical gel used to treat erectile dysfunction. It uses Futura's proprietary technology, DermaSys. The product is now available for purchase online through the BinSina Pharmacy in the UAE, the first market in the Middle East to stock the product.
Read more(Sharecast News) - Sexual health specialist Futura Medical announced the successful acquisition of an EU patent for its MED3000 topical erectile dysfunction product on Monday.
Read moreFutura Medical PLC - Guildford, Surrey-based pharmaceutical company - Receives European patent for erectile dysfunction treatment, MED3000, until 2040. Continues to pursue patent applications to provide wider patent protection. Chief Executive Officer James Barder says: "The allowance of this patent application further cements the intellectual property of MED3000, as we support our distributors' roll out of our fast acting topically applied gel for the treatment of erectile dysfunction available without a doctor's prescription across the world."
Read more(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Read moreTuesday 12 September | |
Associated British Foods PLC | Trading Statement |
Cornerstone FS PLC | Half Year Results |
Creo Medical Group PLC | Half Year Results |
Digital 9 Infrastructure PLC | Half Year Results |
Dowlais Group PLC | Half Year Results |
Eleco PLC | Half Year Results |
Equals Group PLC | Half Year Results |
Feedback PLC | Full Year Results |
Fevertree Drinks PLC | Half Year Results |
Gym Group PLC | Half Year Results |
Harworth Group PLC | Half Year Results |
hVIVO PLC | Half Year Results |
IQE PLC | Half Year Results |
Itaconix PLC | Half Year Results |
JTC PLC | Half Year Results |
Keywords Studios PLC | Half Year Results |
Mattioli Woods PLC | Full Year Results |
Ocean Harvest Technology Group PLC | Half Year Results |
Property Franchise Group PLC | Half Year Results |
Regional REIT Ltd | Half Year Results |
Smart Metering Systems PLC | Half Year Results |
Wednesday 13 September | |
abrdn Smaller Companies Income Trust PLC | Half Year Results |
Argentex Group PLC | Half Year Results |
Brave Bison Group PLC | Half Year Results |
Burford Capital Ltd | Half Year Results |
CAB Payments Holdings PLC | Half Year Results |
Central Asia Metals PLC | Half Year Results |
Frontier Developments PLC | Full Year Results |
Made Tech Group PLC | Full Year Results |
On The Beach Group PLC | Trading Statement |
Pan African Resources PLC | Full Year Results |
Pharos Energy PLC | Half Year Results |
Ricardo PLC | Full Year Results |
Star Energy Group PLC | Half Year Results |
Tullow Oil PLC | Half Year Results |
Thursday 14 September | |
Arecor Therapeutics PLC | Half Year Results |
Brooks Macdonald Group PLC | Full Year Results |
Capricorn Energy PLC | Half Year Results |
Checkit PLC | Half Year Results |
Churchill China PLC | Half Year Results |
Foresight Solar Fund Ltd | Half Year Results |
Glenveagh Properties PLC | Half Year Results |
IG Group Holdings PLC | Trading Statement |
Keystone Law Group PLC | Half Year Results |
Kier Group PLC | Full Year Results |
M&C Saatchi PLC | Half Year Results |
MJ Gleeson PLC | Full Year Results |
Oakley Capital Investments Ltd | Half Year Results |
Renishaw PLC | Full Year Results |
Spire Healthcare Group PLC | Half Year Results |
THG PLC | Half Year Results |
Trainline PLC | Trading Statement |
Uniphar PLC | Half Year Results |
Friday 15 September | |
Petra Diamonds Ltd | Full Year Results |
VH Global Sustainable Energy Opportunities PLC | Half Year Results |
Monday 18 September | |
Artisanal Spirits Co PLC | Half Year Results |
City of London Investment Group PLC | Full Year Results |
Downing Renewables & Infrastructure Trust PLC | Half Year Results |
Facilities by ADF PLC | Half Year Results |
Futura Medical PLC | Half Year Results |
Greencoat Renewables PLC | Half Year Results |
HgCapital Trust PLC | Half Year Results |
Phoenix Group Holdings PLC | Half Year Results |
S4 Capital PLC | Half Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |